Tech Company Inital Public Offerings
Vera Therapeutics IPO
Vera Therapeutics, operating out of San Francisco, had an IPO event on 5/14/2021.
Transaction Overview
Company Name
Announced On
5/14/2021
Transaction Type
IPO
Amount
$48,400,000
Proceeds Purpose
Use of proceeds for the Vera Therapeutics IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
170 Harbor Way 3rd Floor
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Vera Therapeutics is a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases. Vera's mission is to develop and commercialize transformative new therapies that improve patients' lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marshall Fordyce
Chief Financial Officer
Jonathan Wolter
VP - Bus. Development
Joanne Curley
VP - Bus. Development
Lauren Frenz
VP - Operations
Thomas Doan
Browse more venture capital transactions:
Prev: 5/14/2021: Optimal Dynamics venture capital transaction
Next: 5/14/2021: Inari venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs